Lincoln Pharmaceuticals on Thursday reported a net profit of Rs 11.62 crore for the March quarter of 2024-25 and said it is ...

EBITDA improved by 8.20% to Rs 124.47 crore in the fourth quarter from Rs 115.04 crore recorded in the same period last year.

Last checked, the stock was up 2.15 per cent at Rs 787.65. At this price, it has corrected 18.73 per cent on a year-to-date ...

The Aprilia RS457 in question comes priced at Rs 4.20 lakh (ex-showroom) and is aimed at sportbike buyers seeking performance ...

Mankind Pharma slipped 3.51% to Rs 2,444.25 after the company's consolidated net profit declined 10.71% to Rs 420.77 crore in Q4 FY25 as against Rs 471.24 crore posted in Q4 FY24.

The company plans to ramp up its care home bed capacity to 2,000 beds and develop 10–12 new senior living communities.